Company Overview - Insmed Incorporated is a global biopharmaceutical company focused on delivering first- and best-in-class therapies for patients with serious diseases [3][4] - The company is advancing a diverse portfolio of approved and investigational medicines, particularly in pulmonary and inflammatory conditions [3] - Insmed's advanced programs include a therapy approved in the United States, Europe, and Japan for a chronic lung disease [3] Upcoming Event - Management will present at the BofA Securities 2025 Health Care Conference on May 13, 2025, at 2:20 p.m. PT [1] - The event will be webcast live and available for 30 days post-event on the company's investor relations website [2] Company Recognition - Insmed has been recognized as one of the best employers in the biopharmaceutical industry, including being named the No. 1 Science Top Employer for four consecutive years [4]
Insmed To Present at the BofA Securities 2025 Health Care Conference